Key result
A single session of plasmapheresis successfully reduced serum triglyceride levels by 85.6% (from 3170 mg/dL to 457 mg/dL) in a patient with hypertriglyceridemia-induced pancreatitis.
Why the study?
Although the superiority of plasmapheresis for hypertriglyceridemia-induced pancreatitis has not been demonstrated in randomized trials, it is considered a possible alternative according to guidelines.
Does plasmapheresis successfully treat hypertriglyceridemia-induced pancreatitis?
Case Report (n=1)
No
Does plasmapheresis successfully treat hypertriglyceridemia-induced pancreatitis?
Plasmapheresis is a potentially safe and effective alternative treatment for hypertriglyceridemia-induced pancreatitis.
Case report adds anecdotal support for plasmapheresis in hypertriglyceridemia pancreatitis; leaves open need for RCTs to confirm benefit.
Hypertriglyceridemia-induced pancreatitis is a relatively common form of acute pancreatitis that may represent up to 10% of all etiologies of this condition. Due to its specific pathogenic mechanisms related to high serum triglyceride levels, different treatment options have been proposed, including insulin perfusion, heparin perfusion, and plasmapheresis. Although the superiority of plasmapheresis in this clinical setting has not been demonstrated in randomized clinical trials, many centers have reported its effectiveness and considered this as a possible alternative according to the current guidelines. We report a case of a young patient diagnosed with hypertriglyceridemia-induced pancreatitis that was successfully treated with plasmapheresis. Since complications associated with plasmapheresis are rare and other therapeutic options may not be so effective or safe, we believe that this should be a valid alternative treatment that may be offered to these patients. More studies are still needed to further evaluate its effectiveness and to elucidate if there is a subset of patients in whom treatment with plasmapheresis may be more beneficial.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2022) conducted a case report in Hypertriglyceridemia-induced pancreatitis (n=1). Plasmapheresis was evaluated on Triglyceride reduction. A single session of plasmapheresis successfully reduced serum triglyceride levels by 85.6% (from 3170 mg/dL to 457 mg/dL) in a patient with hypertriglyceridemia-induced pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: